H-LPRWYFYYL-OH

Ref. 3D-PP47432

Informations sur le produit

• Nom: H-LPRWYFYYL-OH

Description

Peptide H-LPRWYFYYL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-LPRWYFYYL-OH include the following: CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity THO Nguyen , LC Rowntree , J Petersen , BY Chua - Immunity, 2021 - cell.comhttps://www.cell.com/immunity/pdf/S1074-7613(21)00171-0.pdf High Precursor Frequency and Promiscuity in Αbeta T Cell Receptor Pairing Underpin CD8+ T-Cell Responses to an Immunodominant SARS-CoV-2 Nucleocapsid THO Nguyen , LC Rowntree , J Petersen , B Chua - 2021 - papers.ssrn.comhttps://papers.ssrn.com/sol3/papers.cfm?abstract_id=3751796 Sars-arena: Sequence and structure-guided selection of conserved peptides from sars-related coronaviruses for novel vaccine development MM Rigo , R Fasoulis , A Conev , S Hall-Swan - Frontiers in , 2022 - frontiersin.orghttps://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.931155 Architecture of the SARS-CoV-2-specific T cell repertoire KV Zornikova , SA Sheetikov , AY Rusinov - Frontiers in , 2023 - frontiersin.orghttps://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1070077/full CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses KE Lineburg , EJ Grant , S Swaminathan - Immunity, 2021 - cell.comhttps://www.cell.com/immunity/pdf/S1074-7613(21)00168-0.pdf Pre-existing cellular immunity to SARS-CoV-2 through an immunodominant epitope KE Lineburg , EJ Grant , S Swaminathan - 2021 - papers.ssrn.comhttps://papers.ssrn.com/sol3/papers.cfm?abstract_id=3774361 Most Japanese individuals are genetically predisposed to recognize an immunogenic protein fragment shared between COVID-19 and common cold JM Dijkstra , AP Frenette, B Dixon - F1000Research, 2021 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108557/

• Marque: Biosynth